Approach to Pleural Cancer: State of the Art
Not eligible for ESCO credits
07.05.2009 - 08.05.2009
Athens, Greece
COURSES AND SEMINARS
Description
Malignant pleural effusions complicate most cancers: 95% of patient with mesothelioma, 30% of those with breast and 25% of those with lung cancer develop a malignant effusion. Malignant involvement of the pleura often results in disabling dyspnea from effusions, pain and drastically impairs quality of life. Despite its frequent occurrence, management of malignant effusions are often handled late and sub-optimally. Significantand exciting advances have been made recently in the field of the treatment of malignant pleural diseases, many of which impacts directly on the care of patients. This proposed course presents a unique opportunity to bring together leading clinical pleural researchers with strong track records and international speaking experiences to provide a concise update on the latest advances in the approach to pleural malignancies, from new etiologic concepts to clinical evidence that changes patient care, including new international guidelines on pleural disease management. The audience will be informed with up-to-date understanding of concepts of pathogenesis as well as practical guides to management of pleural malignancies, allowing participants to gain insight and confidence in the care of patients with pleural cancers. A first ESO course on malignant mesothelioma was held in Brussels in 2007 and was considered successful. By expanding the programme to other pleural malignancies, we are confident that the proposed course will raise the awareness and management standard for patients with malignant pleural diseases.
I. Kalomenidis and J.P. van Meerbeeck
TARGET AUDIENCE
Practicing pulmonologists, medical and radiation oncologists, palliative care physicians, internists, radiologists, and trainees in these specialities, related health care professionals especially cancer nurses.
Under the auspices of
General information
OFFICIAL LANGUAGE
The official language of the course will be English. No simultaneous translation will be provided.
CERTIFICATES
All participants will be issued with a certificate of attendance at the close of the course.
BADGE
The badge is the only official evidence of registration and should be worn at all times during the course. Loss of badge means loss of registration.
INSURANCE
The organisers bear no responsibility for untoward events in connection with, before, during and after the course. Participants are strongly advised to take out their own personal and travel insurance coverage.
ACCREDITATION
The course has been accredited by the Belgian Social Security (RIZIV) with 10 Credit Points in Category 4 with number 08000768.